Barrett's oesophagus: Microsatellite analysis provides evidence to support the proposed metaplasia-dysplasia-carcinoma sequence

Genes Chromosomes and Cancer

Volumn 21, Issue 1, 1998, Pages 49-60

  Gleeson, Catherine M ^a   Sloan, James M ^b   McGuigan, James A ^b   Ritchie, Andrew J ^b   Weber, James L ^c   Russell, S E Hilary ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b ROYAL VICTORIA HOSPITAL   (United Kingdom)

^c MARSHFIELD CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BARRETT ESOPHAGUS; CHROMOSOME 12P; CHROMOSOME 12Q; CHROMOSOME 17P; CHROMOSOME 18Q; CHROMOSOME 3Q; CHROMOSOME 4Q; CHROMOSOME 5Q; CHROMOSOME 6Q; CHROMOSOME 9P; CHROMOSOME 9Q; CLINICAL ARTICLE; CONTROLLED STUDY; DYSPLASIA; ESOPHAGUS CARCINOMA; HUMAN; HUMAN TISSUE; METAPLASIA; PRIORITY JOURNAL;

ADENOCARCINOMA; BARRETT ESOPHAGUS; CELL TRANSFORMATION, NEOPLASTIC; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; HUMANS; METAPLASIA; MICROSATELLITE REPEATS;

EID: 0031974327     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199801)21:1<49::AID-GCC7>3.0.CO;2-8     Document Type: Article

References (46)

1. Barren MT, Galipeau PC, Sanchez CA, Emond MJ, Reid BJ (1996a) Determination of the frequency of loss of heterozygosity in esophageal adenocarcinoma by cell sorting, whole genome amplification and microsatellite polymorphisms. Oncogene 12: 1873-1878.
2. Barrett MT, Sanchez CA, Galipeau PC, Neshat K, Emond M, Reid BJ (1996b) Allelic loss of 9p21 and mutation of the CKN2/p16 gene develop as early lesions during neoplastic progression in Barren's esophagus. Oncogene 13: 1867-1873.
3. Beahrs OH, Henson D, Hutter RVP, Myers MH (1988) Manual for staging cancer, American Joint Committee on Cancer. Philadelphia: JB Lippincott.
4. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF (1991) Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 265: 1287-1289.
5. Blount PL, Ramel S, Raskind WH, Haggitt RC, Sanchez CA, Dean PJ, Rabinovitch PS, Reid BJ (1991) 17p allelic deletions and p53 protein overexpression in Barrett's adenocarcinoma. Cancer Res 51: 5482-5486.
6. Blount PL, Meltzer SJ, Yin J, Huang Y, Krasna MJ, Reid BJ (1993) Clonal ordering of 17p and 5q allelic losses in Barrett's dysplasia and adenocarcinoma. Proc Natl Acad Sci USA 90: 3221-3225.
7. Blount PL, Galipeau PC, Sanchez CA, Neshat K, Levine DS, Yin J, Suzuki H, Abraham JM, Meltzer SJ, Reid BJ (1994) 17p allelic losses in diploid cells of patients with Barrett's esophagus who develop aneuploidy. Cancer Res 54: 2292-2295.
8. Boynton RF, Huang Y, Blount PL, Reid BJ, Raskind WH, Haggitt RC, Newkirk C, Resau JH, Yin J, McDaniel T, Meltzer SJ (1991) Frequent loss of heterozygosity at the retinoblastoma locus in human esophageal cancers. Cancer Res 51: 5766-5769.
9. Boynton RF, Blount PL, Yin J, Brown VL, Huang Y, Tong Y, McDaniel T, Newkirk C, Resau JH, Raskind WH, Haggitt RC, Reid BJ, Meltzer SJ (1992) Loss of heterozygosity involving the APC and MCC genetic loci occurs in the majority of human esophageal cancers. Proc Natl Acad Sci USA 89: 3385-3388.
10. Buetow KH, Murray JC, Israel JL, London WT, Smith M, Klew M, Blanquet V, Brechot C, Redeker A, Govindarajah S (1989) Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellutar carcinoma. Proc Natl Acad Sci USA 86: 8852-8856.
11. Gleeson CM, Sloan JM, McGuigan JA, Ritchie AJ, Russell SEH (1995) Base Transitions at CpG dinucleotides in the p53 gene are common in oesophageal adenocarcinoma. Cancer Res 55: 3406-3411.
12. Gleeson CM, Sloan JM, McGuigan JA, Ritchie AJ, Weber JL, Russell SEH (1996) Ubiquitous somatic alterations at microsatellite alleles occur infrequently in Barrett's-associated oesophageal adenocarcinoma. Cancer Res 56: 259-263.
13. Gottfried MR, McClave SA, Boyce HW (1989) Incomplete intestinal metaplasia in the diagnosis of columnar lined esophagus (Barrett's esophagus). Am J Clin Pathol 92: 741-746.
14. Gruis NA, Abeln ECA, Bardoel AFJ, Devilee P, Frants RR, Cornelisse CJ (1993) PCR-based microsatellite polymorphisms in the detection of loss of heterozygosity in fresh and archival tumour tissue. Br J Cancer 68: 308-313.
15. Haggitt RC, Tryzelaar J, Ellis FH, Colcher H (1978) Adenocarcinoma complicating columnar epithelium-lined (Barrett's) esophagus. Am J Clin Pathol 70: 1-5.
16. Hameeteman W, Tytgat GNJ, Houthoff HJ, van den Tweel JG (1989) Barrett's esophagus: Development of dysplasia and adenocarcinoma. Gastroenterology 96: 1249-1256.
17. Hamelin R, Fléjou J-F, Muzeau F, Potet F, Laurent-Puig P, Fékété F, Thomas G (1994) TP53 gene mutations and p53 protein immunoreactivity in malignant and premalignant Barrett's esophagus. Gastroenterology 107: 1012-1018.
18. Hammound ZT, Kaleem Z, Cooper JD, Sundaresan RS, Patterson GA, Goodfellow PJ (1996) Allelotype analysis of esophageal adenocarcinomas: Evidence for the involvement of sequences on the long arm of chromosome 4. Cancer Res 56: 4499-4502.
19. Hermanek P, Sobin LH (1987) Classification of malignant tumors. Berlin, New York: Springer-Verlag.
20. Huang Y, Boynton RF, Blount PL, Silverstein RJ, Yin J, Tong Y, McDaniel TK, Newkirk C, Resau JH, Sridhara R, Reid BJ, Meltzer SJ (1992) Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers. Cancer Res 52: 6526-6530.
21. Iascone C, DeMeester TR, Little AG, Skinner DB (1983) Barrett's esophagus. Functional assessment, proposed pathogenesis, and surgical therapy. Arch Surg 118: 543-549.
22. Laird PW, Zijderveld A, Linders K, Rudnicki MA, Jaenisch R, Berns A (1991) Simplified mammalian DNA isolation procedure. Nucleic Acids Res 19: 4293.
23. Lauren P (1965) The two histological main types of gastric adenocarcinoma: diffuse and so-called intestinal-type adenocarcinoma. Acta Pathol Microbiol Immunol Scand 5: 145-153.
24. Levine DS, Rubin CE, Reid BJ, Haggitt RC (1989) Specialized metaplastic columnar epithelium in Barrett's esophagus. A comparative transmission electron microscopic study. Lab Invest 60: 418-432.
25. McArdle JE, Lewin KJ, Randall G, Weinstein W (1992) Distribution of dysplasias and early invasive carcinoma in Barrett's esophagus. Hum Pathol 23: 479-482.
26. Meltzer SJ, Yin J, Huang Y, McDaniel TK, Newkirk C, Iseri O, Vogelstein B, Resau JH (1991) Reduction to homozygosity involving p53 in esophageal cancers demonstrated by the polymerase chain reaction. Proc Natl Acad Sci USA 88: 4976-4980.
27. Mitra AB, Murty VS, Li RG, Pratap M, Luchra UK, Chaganti RSK (1994) Allelotype analysis of cervical carcinoma. Cancer Res 54: 4481-4487.
28. Neshat K, Sanchez CA, Galipeau PC, Blount PL, Levine DS, Joslyn G, Reid BJ (1994) p53 mutations in Barrett's adenocarcinoma and high-grade dysplasia. Gastroenterology 106: 1589-1595.
29. Ning Y, Weber JL, Killary AM, Ledbetter DH, Smith JR, Pereira-Smith OM (1991) Genetic analysis of indefinite division in human cells: Evidence for a cell senescence-related gene(s) on human chromosome 4. Proc Natl Acad Sci USA 88: 5635-5639.
30. Nowell PC (1976) The clonal evolution of tumor cell populations. Science 194: 23-28.
31. Nowell PC (1986) Mechanisms of tumor progression. Cancer Res 46: 2203-2207.
32. Polascik TJ, Cairns P, Chang WYH, Schoenberg MP, Sidransky D (1995) Distinct regions of allelic loss on chromosome 4 in human primary bladder carcinoma. Cancer Res 55: 5396-5399.
33. Powell J, McConkey CC (1990) Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites. Br J Cancer 62: 440-443.
34. Rabinovitch PS, Reid BJ, Haggitt RC, Norwood TH, Rubin CE (1988) Progression to cancer in Barrett's esophagus is associated with genomic instability. Lab Invest 60: 65-71.
35. Reid BJ, Haggitt RC, Rubin CE, Roth G, Surawicz CM, van Belle G, Lewin K, Weinstein WM, Antonioli DA, Goldman H, MacDonald W, Owen D (1988a) Observer variation in the diagnosis of dysplasia in Barrett's esophagus. Hum Pathol 19: 166-178.
36. Reid BJ, Weinstein WM, Lewin KJ, Haggitt RC, van Deventer G, den Besten L, Rubin CE (1988b) Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions. Gastroenterology 94: 81-90.
37. Reid BJ, Blount PL, Rubin CE, Levine DS, Haggitt RC, Rabinovitch PS (1992) Flow-eytometric and histological progression to malignancy in Barren's esophagus: Prospective endoscopie surveillance of a cohort. Gastroenturology 102: 1212-1219.
38. Speehler SJ, Rubbins AH, Bloomfield Rubins H, Vincent ME, Heeren T, Duos WG, Colton T, Schimmel EM (1984) Adenocarcinoma and Barrett's esophagus: An overrated risk? Gastroenterology 87:927-933.
39. Swift A, Risk JM, Kingsnorth AN, Wright TA, Myskow M, Field JK (1995) Frequent loss of heterozygosity on chromosome 17 at 17q11.2-q12 in Barrett's adenocarcinoma. Br J Cancer 71: 995-998.
40. Tarmin L, Yin J, Zhou X, Suzuki H, Jiang H-Y, Rhyu M-G, Abraham JM, Krasna MJ, Cottrell J, Meltzer SJ (1994) Frequent loss of heterozygosity on chromosome 9 in adenocarcinoma and squamous cell carcinoma of the esophagus. Cancer Res 54: 6094-6096.
41. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AMM, Bos JL (1988) Genetic alterations during colorectal-tumor development. New Engl J Med 319: 525-532.
42. Vogelstein B, Fearon ER, Kern SE, Hamilton SR, Preisinger AC, Nakamura Y, White R (1989) Allelotype of colorectal carcinomas. Science 244: 207-211.
43. Wada M, Yokota J, Mizoguchi H, Sugimura T, Terada M (1988) Infrequent loss of chromosomal heterozygosity in human stomach cancer. Cancer Res 48: 2988-2992.
44. Yen S-H, Chen M-Y, Lai M-Y, Chen D-S (1996) Allelic loss on chromosomes 4q and 16q in hepatocellular carcinoma: Association with elevated alpha-fetoprotein production. Gastroenterology 110: 184-192.
45. Zhou X, Tarmin L, Yin J, Jiang H-Y, Suzuki H, Rhyu M-G, Abraham JM, Meltzer SJ (1994) The MTS1 gene is frequently mutated in primary human esophageal tumors. Oncogene 9: 3737-3741.
46. Zhuang Z, Vortmeyer AO, Mark EJ, Odze R, Emmert-Buck MR, Merino MJ, Moon H, Liotta LA, Duruy PH (1996) Barrett's Esophagus: Metaplastic cells with loss of heterozygosity at the APC gene locus are clonal precursors to invasive adenocarcinoma. Cancer Res 56: 1961-1964.